A Tennessee death row inmate remained alive after officials attempted to execute her with lethal injection, creating an extraordinary situation that has prompted an investigation into the state’s execution procedures.
Christa Pike, 50, was scheduled to be executed on September 30 for the 1995 murder of Colleen Slemmer. She would have been the first woman executed in Tennessee in more than 200 years.
The execution took place after hours of legal uncertainty.
Pike’s attorneys had asked courts to stop the execution, citing her history of childhood sexual abuse, trauma and other circumstances that they said deserved consideration.
A federal appeals court temporarily halted the execution on Wednesday morning. Tennessee officials then appealed to the U.S. Supreme Court.
The Supreme Court overturned the stay, clearing the way for the execution to proceed.
The lethal-injection process eventually began at Riverbend Maximum Security Institution in Nashville.
Media witnesses watched from a separate chamber.
Pike was reportedly placed on a gurney and began speaking before the procedure. She reportedly expressed love and peace during what she believed would be her final moments.
Officials then administered pentobarbital.
However, the procedure did not result in Pike’s death.
Her attorneys said two doses were administered. Witnesses later reported hearing Pike breathing and snoring. She reportedly remained alive for a prolonged period.
At one point, Pike was said to have raised her head and questioned prison officials about a sensation in her arm.
The curtains were closed during portions of the process, leaving witnesses unable to see exactly what was happening inside.
Eventually, journalists were ordered to leave.
An ambulance was seen leaving the prison, and Pike’s attorneys later confirmed that she had been taken to a hospital.
Her condition was not immediately disclosed.
The Tennessee Department of Correction confirmed her transfer to an off-site medical facility but said that officials had followed the state’s approved execution protocol.
The department’s position contrasts with the claims made by Pike’s attorneys, who argued that the procedure caused unnecessary suffering and violated their client’s constitutional rights.
The lawyers had previously raised concerns about possible problems with the execution process. After the attempt, they said those concerns had materialized.
The incident has attracted national attention because failed lethal-injection attempts are rare, particularly when an inmate survives after receiving the drugs intended to cause death.
Death-penalty experts cited in reports said previous botched executions have generally involved difficulties establishing intravenous access. Pike’s case is unusual because she reportedly received the lethal drug itself and nevertheless remained alive.
The Tennessee governor responded by suspending all remaining scheduled executions for 2026.
Governor Lee also ordered a comprehensive third-party review.
The review is expected to examine how the execution was conducted and why it did not produce the intended result.
The episode follows another failed execution in Tennessee earlier this year involving death row inmate Tony Carruthers.
That earlier incident involved difficulties establishing intravenous access and eventually led to a one-year reprieve.
The latest incident has therefore intensified questions about Tennessee’s execution procedures.
Meanwhile, Pike’s legal team continues to pursue emergency court action.
The lawyers have asked courts to halt further efforts to execute her while challenging what happened during the failed procedure.
It remains unclear what legal action Tennessee will take after the review.
Pike’s death sentence itself stems from the murder of Slemmer in 1995. Pike has acknowledged responsibility for the crime while her attorneys have argued that her youth and history of severe abuse should be considered in deciding her punishment.
The failed execution has transformed what was expected to be a historic execution in Tennessee into an unprecedented legal and medical controversy.
